IL6 and metabolic syndrome: For example, in previous studies with young ZDF (Zucker diabetic fatty) rats, an experimental model of the metabolic syndrome and type 2 diabetes, oral administration of melatonin reduced the levels of pro-inflammatory cytokines such as IL-6, TNF-α, and CRP, oxidative stress or low-grade inflammation [55].